agilon health, inc. (NYSE:AGL - Get Free Report)'s share price rose 5.9% during mid-day trading on Tuesday . The stock traded as high as $3.43 and last traded at $3.49. Approximately 1,091,581 shares changed hands during trading, a decline of 77% from the average daily volume of 4,785,858 shares. The stock had previously closed at $3.29.
Analyst Upgrades and Downgrades
AGL has been the subject of several analyst reports. Sanford C. Bernstein raised their price target on shares of agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a report on Wednesday, January 15th. Macquarie initiated coverage on shares of agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 price target for the company. Barclays lowered their price target on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a report on Monday, November 11th. Stifel Nicolaus lowered their price objective on shares of agilon health from $7.00 to $2.00 and set a "hold" rating for the company in a research note on Tuesday, November 12th. Finally, JMP Securities lowered shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $4.03.
Read Our Latest Research Report on agilon health
agilon health Stock Down 1.6 %
The firm has a market cap of $1.41 billion, a P/E ratio of -3.64 and a beta of 0.67. The stock's 50 day simple moving average is $2.69 and its 200 day simple moving average is $3.22. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.
Insider Buying and Selling at agilon health
In other news, Director Karen Mcloughlin acquired 25,000 shares of the business's stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares of the company's stock, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Diana Mckenzie acquired 12,500 shares of the business's stock in a transaction on Monday, November 25th. The shares were purchased at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the acquisition, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 90,000 shares of company stock worth $198,100. 3.20% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On agilon health
Hedge funds have recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health during the 3rd quarter worth $28,000. Oak Thistle LLC purchased a new position in agilon health during the 4th quarter worth $25,000. Ieq Capital LLC purchased a new position in shares of agilon health in the 4th quarter worth about $26,000. Signaturefd LLC boosted its holdings in shares of agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after buying an additional 8,467 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of agilon health in the 4th quarter worth about $33,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.